Brief study of hypertrichosis

Hypertrichosis, defined as excessive hair growth above the normal range for age, sex, and ethnicity, poses both cosmetic and psychological problems, especially in women and children. In contrast to hirsutism (androgen-induced male-pattern hair growth), hypertrichosis is abnormal proliferation of lanugo, vellus, or terminal hair and may be congenital or acquired. Congenital types, like hypertrichosis lanuginosa or Ambras syndrome, usually connect with genetic mutation, whereas developed cases might originate from drugs (e.g., minoxidil, phenytoin), metabolic disorders, or malignancy. Diagnosis is based on clinical assessment, dermoscopy, and occasionally genetic analysis, particularly in syndromic presentations. Management is diverse drug-induced hypertrichosis can reverse on withdrawal of the causative drug, while irreversible methods such as laser or electrolysis are offered for long term control. In children, minimally invasive procedures (shaving, trimming) are utilized owing to sensitivity to pain. Novel topical drugs, including capryloyl glycine, have potential to decrease hair growth by inhibiting follicular activity. Although hypertrichosis is largely a cosmetic issue, in some cases it may indicate hidden systemic diseases that need a good medical evaluation. Successful treatment often involves a differential approach, weighed against patient tolerance, psychological welfare, and therapy effectiveness. Investigating the genotypic and molecular underpinnings through future studies promises to open additional targeted treatments of this fascinating cutaneous condition.